Yes, intravenous thrombolysis should be administered in pregnancy when other clinical and imaging factors are favorable

Stroke

Volumn 44, Issue 3, 2013, Pages 864-865

  Demchuk, Andrew M ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

Endovascular treatment; Middle cerebral artery occlusion; MRI; Pregnancy; Thrombolysis

Indexed keywords

TISSUE PLASMINOGEN ACTIVATOR;

ARTICLE; BLOOD CLOT LYSIS; BRAIN HEMORRHAGE; DIFFUSION WEIGHTED IMAGING; HUMAN; MIDDLE CEREBRAL ARTERY OCCLUSION; PERFUSION WEIGHTED IMAGING; PRIORITY JOURNAL; RATING SCALE;

ADMINISTRATION, INTRAVENOUS; ADULT; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; RISK ASSESSMENT; STROKE; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR;

EID: 84876266390     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.111.000134     Document Type: Article

References (8)

1. Yamaguchi Y, Kondo T, Ihara M, Kawamata J, Fukuyama H, Takahashi R. Intravenous recombinant tissue plasminogen activator in an 18-week pregnant woman with embolic stroke. Rinsho Shinkeigaku. 2010;50:315-319.
2. Tassi R, Acampa M, Marotta G, Cioni S, Guideri F, Rossi S et al. Systemic thrombolysis for stroke in pregnancy. Am J Emerg Med; August 6, 2012. DOI: 10.1016/j.ajem.2012.05.040. http://www.ajemjournal.com/article/ S0735-6757(12)00269-0/fulltext.
3. Cronin CA, Weisman CJ, Llinas RH. Stroke treatment: beyond the three-hour window and in the pregnant patient. Ann N Y Acad Sci. 2008;1142:159-178.
4. Menon BK, Saver JL, Prabhakaran S, Reeves M, Liang L, Olson DM, et al. Risk score for intracranial hemorrhage in patients with acute ischemic stroke treated with intravenous tissue-type plasminogen activator. Stroke. 2012;43:2293-2299.
5. Olivot JM, Mlynash M, Thijs VN, Kemp S, Lansberg MG, Wechsler L, et al. Optimal Tmax threshold for predicting penumbral tissue in acute stroke. Stroke. 2009;40:469-475.
6. Parsons MW, Christensen S, McElduff P, Levi CR, Butcher KS, De Silva DA, et al; Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET) Investigators. Pretreatment diffusion-and perfusion-MR lesion volumes have a crucial influence on clinical response to stroke thrombolysis. J Cereb Blood Flow Metab. 2010;30:1214-1225.
7. Saqqur M, Uchino K, Demchuk AM, Molina CA, Garami Z, Calleja S, et al; CLOTBUST Investigators. Site of arterial occlusion identified by transcranial Doppler predicts the response to intravenous thrombolysis for stroke. Stroke. 2007;38:948-954.
8. Akhter T, Larsson A, Larsson M, Wikstrom AK, Naessen T. Artery wall layer dimensions during normal pregnancy-a longitudinal study using non-invasive high-frequency ultrasound. Am J Physiol Heart Circ Physiol. 2013;304:H229-234.